Mechanisms of action of PDE5 inhibition in erectile dysfunction

International Journal of Impotence Research

Volumn 16, Issue SUPPL. 1, 2004, Pages

  Corbin, J D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclic GMP; Impotence; Penile erection; Phosphodiesterase inhibitors; Vasodilator agents

Indexed keywords

ARGININE; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; PHOSPHODIESTERASE; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ARTERY DILATATION; ARTERY MUSCLE; ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM CELL LEVEL; CORPUS CAVERNOSUM; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ERECTILE DYSFUNCTION; GAF DOMAIN; HUMAN; MALE; NEGATIVE FEEDBACK; NERVE; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SMOOTH MUSCLE RELAXATION; SPINAL REFLEX; VENOCONSTRICTION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CALCIUM; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; IMPOTENCE; MALE; MUSCLE, SMOOTH; PENILE ERECTION; PENIS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PIPERAZINES;

EID: 3342962358     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901205     Document Type: Article

References (17)

1. Boolell M et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
2. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257-261.
3. Rajfer J et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90-94.
4. Trigo-Rocha F et al. Intracellular mechanism of penile erection in monkeys. Neurourol Urodyn 1994; 13: 71-80.
5. Chuang T, Strauss JD, Murphy RA, Steers WD. Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 1998; 160: 257-261.
6. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-748.
7. Fisher DA et al. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 1998; 246: 570-577.
8. Soderling SH, Bayuga SJ, Beavo JA. Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J Biol Chem 1998; 273: 15553-15558.
9. Fawcett L et al. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 2000; 97: 3702-3707.
10. Kuthe A et al. Expression of different phosphodiesterase genes in human cavernous smooth muscle. J Urol 2001; 165: 280-283.
11. Fink TL et al. Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). J Biol Chem 1999; 274: 34613-34620.
12. Thomas MK, Francis SH, Corbin JD. Substrate-and-kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP. J Biol Chem 1990; 265: 124971-124978.
13. Liu L et al. Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase. Cell Signal 2002; 14: 45-51.
14. Gopal VK, Francis SH, Corbin JD. Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum. Eur J Biochem 2001; 268: 3304-3312.
15. Corbin JD, Turko IV, Beasley A, Francis SH. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem 2000; 267: 2760-2767.
16. Wyatt TA, Naftilan AJ, Francis SH, Corbin JD. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am J Physiol 1998; 274: H448-H455.
17. Rybalkin SD et al. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells. J Biol Chem 2002; 277: 3310-3317.